These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30899371)

  • 21. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
    Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
    J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane).
    Chakravarti N; Myers JN; Aggarwal BB
    Int J Cancer; 2006 Sep; 119(6):1268-75. PubMed ID: 16642480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway.
    Chang WM; Chang YC; Yang YC; Lin SK; Chang PM; Hsiao M
    J Exp Clin Cancer Res; 2019 Jun; 38(1):245. PubMed ID: 31182137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-204 inhibits angiogenesis and promotes sensitivity to cetuximab in head and neck squamous cell carcinoma cells by blocking JAK2-STAT3 signaling.
    Wu Q; Zhao Y; Wang P
    Biomed Pharmacother; 2018 Mar; 99():278-285. PubMed ID: 29353201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel member of the STOMATIN/EPB72/mec-2 family, stomatin-like 2 (STOML2), is ubiquitously expressed and localizes to HSA chromosome 9p13.1.
    Owczarek CM; Treutlein HR; Portbury KJ; Gulluyan LM; Kola I; Hertzog PJ
    Cytogenet Cell Genet; 2001; 92(3-4):196-203. PubMed ID: 11435687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD100-plexin-B1 induces epithelial-mesenchymal transition of head and neck squamous cell carcinoma and promotes metastasis.
    Zhang C; Qiao H; Guo W; Liu Y; Yang L; Liu Y; Jin B; Fu M; Wang G; Li W
    Cancer Lett; 2019 Jul; 455():1-13. PubMed ID: 30981760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
    Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
    Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
    Zhang F; Li Y; Zhang H; Huang E; Gao L; Luo W; Wei Q; Fan J; Song D; Liao J; Zou Y; Liu F; Liu J; Huang J; Guo D; Ma C; Hu X; Li L; Qu X; Chen L; Yu X; Zhang Z; Wu T; Luu HH; Haydon RC; Song J; He TC; Ji P
    Oncotarget; 2017 Feb; 8(8):12968-12982. PubMed ID: 28099902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of TP63 Promotes the Metastasis of Head and Neck Squamous Cell Carcinoma by Activating MAPK and STAT3 Signaling.
    Lakshmanachetty S; Balaiya V; High WA; Koster MI
    Mol Cancer Res; 2019 Jun; 17(6):1279-1293. PubMed ID: 30910837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced proliferation and colony formation of head and neck squamous cell carcinoma (HNSCC) after dual targeting of EGFR and hedgehog pathways.
    Liebig H; Günther G; Kolb M; Mozet C; Boehm A; Dietz A; Wichmann G
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):411-420. PubMed ID: 28110457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
    Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
    Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
    Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling.
    Yang S; Ji Q; Chang B; Wang Y; Zhu Y; Li D; Huang C; Wang Y; Sun G; Zhang L; Guan Q; Xiang J; Wei W; Lu Z; Liao T; Meng J; Wang Z; Ma B; Zhou L; Wang Y; Yang G
    Oncotarget; 2017 Jan; 8(4):5976-5991. PubMed ID: 27863406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.
    Chang YC; Chi LH; Chang WM; Su CY; Lin YF; Chen CL; Chen MH; Chang PM; Wu AT; Hsiao M
    J Hematol Oncol; 2017 Jan; 10(1):11. PubMed ID: 28061796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth.
    Sen M; Pollock NI; Black J; DeGrave KA; Wheeler S; Freilino ML; Joyce S; Lui VW; Zeng Y; Chiosea SI; Grandis JR
    Neoplasia; 2015 Mar; 17(3):256-64. PubMed ID: 25810010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calprotectin and the Initiation and Progression of Head and Neck Cancer.
    Argyris PP; Slama ZM; Ross KF; Khammanivong A; Herzberg MC
    J Dent Res; 2018 Jun; 97(6):674-682. PubMed ID: 29443623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
    Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
    Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma.
    Oyesanya RA; Bhatia S; Menezes ME; Dumur CI; Singh KP; Bae S; Troyer DA; Wells RB; Sauter ER; Sidransky D; Fisher PB; Semmes OJ; Dasgupta S
    Oncoscience; 2014; 1(11):725-737. PubMed ID: 25593999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ataxia-telangiectasia mutated interactor regulates head and neck cancer metastasis via KRas expression.
    Li YJ; Lai WT; Chang CC; Kuo MY; Deng YT; Yang CN; Cheng SJ; Wu TS; Chen ST; Lin BR
    Oral Oncol; 2017 Mar; 66():100-107. PubMed ID: 28012797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of TRIM24 Stimulates Proliferation and Glucose Metabolism of Head and Neck Squamous Cell Carcinoma.
    Wang H; Xue W; Jiang X
    Biomed Res Int; 2018; 2018():6142843. PubMed ID: 29862279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.